Supraclavicular lymphadenopathy following COVID-19 vaccination: an increasing presentation to the two-week wait neck lump clinic?

• Published in: British journal of oral & maxillofacial surgery Vol. 59; no. 3; pp. 384 - 385
• Main Authors: Mitchell, O.R., Dave, R., Bekker, J., Brennan, P.A.
• Format: Journal Article
• Language: English
• Published: Scotland Elsevier Ltd 01-04-2021; The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd
• Subjects: COVID-19; COVID-19 Vaccines; Humans; lymphadenopathy; Lymphadenopathy - etiology; neck lump; SARS-CoV-2; Short Communication; Vaccination - adverse effects; COVID-19; lymphadenopathy; neck lump
• ISSN: 0266-4356; 1532-1940
• DOI: 10.1016/j.bjoms.2021.02.002

The first COVID-19 vaccination was given in December 2020 and there is an effort to vaccinate the international population on a massive scale. Common side effects from the vaccine include headache and tiredness. Regional lymphadenopathy has been described in relation to other vaccines. We describe two cases of supraclavicular reactive lymphadenopathy presenting in patients who had the COVID vaccination in the ipsilateral arm. Awareness of this diagnosis is important for patients presenting to the neck lump clinic.